Can inflammatory clues predict kidney damage in ICU patients?

NCT ID NCT03720860

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at 100 intensive care patients to see if certain inflammatory markers in urine, blood, and sputum can help predict acute kidney injury. The researchers are comparing patients with sepsis, those recovering from major surgery, and non-inflamed individuals. The goal is to better understand how inflammation may lead to kidney damage.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help identify early warning signs for acute kidney injury in critically ill patients.

What could go wrong

This is an observational study with only 100 participants, so results may not apply to all patients. It aims to understand the disease, not test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute kidney injury infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Akademiska sjukhuset, Centraloperation

    RECRUITING

    Uppsala, Uppsala County, 75185, Sweden

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact